Track Cryoport, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Cryoport, Inc. CYRX · Stock Open Cryoport, Inc. in new tab

19.89 USD
EPS
-0.90
P/B
2.32
ROE
-7.44
Beta
1.87
Target Price
22.33 USD
Cryoport, Inc. logo

Cryoport, Inc.

🧾 Earnings Recap – Q3 2025

Cryoport delivered strong third-quarter performance, achieving double-digit growth in both its Life Sciences Services and Products segments, bolstered by significant demand for cell and gene therapy support.

  • Revenue from commercial cell and gene therapy surged 36% year-over-year to $8.3 million, reflecting robust market adaptation.
  • Overall Life Sciences revenue rose 16% year-over-year, accounting for 55% of total revenue from continuing operations.
  • The launch of next-generation cryogenic systems and new cryopreservation services positions Cryoport for further growth and market leadership.
  • A new state-of-the-art global supply chain center opened in Paris enhances service capabilities in European and global markets.
  • Strategic partnership with DHL Group poised to bolster market presence in the APAC and EMEA regions over time.
📅
Loading chart...
Key Metrics
Earnings dateMarch 2, 2027
EPS-0.90
Book Value8.59
Price to Book2.32
Debt/Equity47.88
% Insiders4.735%
Growth
Revenue Growth0.14%
Estimates
Forward P/E-38.01
Forward EPS-0.52
Target Mean Price22.33

DCF valuation

Model fair value for Cryoport, Inc. (CYRX)
Result
Sign in to run the valuation for CYRX.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
9 analysts · consensus Strong buy · mean target 22.33 USD (low 18.00, high 28.00) · as of 15 Nov 2026
Low 18.00
Mean 22.33
High 28.00
Price 19.89
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Cryoport, Inc. Logo Cryoport, Inc. Analysis (CYRX)

United States Industrials Official Website Stock

Is Cryoport, Inc. a good investment? Cryoport, Inc. (CYRX) is currently trading at 19.89 USD. Market analysts have a consensus price target of 22.33 USD. This suggests a potential upside from current levels.

Earnings Schedule: Cryoport, Inc. is expected to release its next earnings report on March 2, 2027. The market consensus estimate for Forward EPS is -0.52.

Investor FAQ

Does Cryoport, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Cryoport, Inc.?

Cryoport, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 2, 2027. The company currently has a trailing EPS of -0.90.

Company Profile

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

Exchange Ticker
NMS (United States) CYRX
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Feb. 5, 2010 1:10
May 19, 2015 0.08
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion